IP Library Granted Patent US 10,894,074
Granted Patent B2
US 10,894,074 · App. 16/178,693 · Granted Jan 19, 2021

Multi-factor hair growth formulation

Inventor: James Bartholomeusz (Beverly Hills, CA)
Assignee: SKINQRI, LLC
A61K38/02A61K8/64A61K9/0014A61K9/127A61K9/51A61K35/16A61K38/18A61K38/1808A61K38/1825A61K38/1866A61K38/2278A61K38/2292A61K38/27A61K38/30A61P17/00A61P17/04A61Q7/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,894,074
App. No.
16/178,693
Granted
Jan 19, 2021
Kind
B2
Abstract

A synergistic, multi-factor hair growth formulation and its method of use are described. A plurality of synthetic peptides and proteins are selected to maximize efficacy at discrete stages of the anagenic growth phase of a hair follicle, and these compounds may be further coated to promote uptake into the skin and/or hair root. The formulation itself is topical, so as to allow for direct, selective application alone or in combination with mechanical or energetic delivery techniques.

Claims (18)

1. A topical mixture of active ingredients for promoting all stages during an anagenic phase of human hair growth, the mixture comprising:

a combination of synthetic peptides including sh-oligopeptide-1, sh-oligopeptide-4, sh-polypeptide-7, sh-polypeptide-11, and sh-polypeptide-71; and

inactive components.

2. The topical mixture according to claim 1 wherein the inactive components include an encapsulating material.

3. The topical mixture according to claim 2 wherein the encapsulating material is a nanoliposome.

4. The topical mixture according to claim 3 wherein at least one of the synthetic peptides is individually encapsulated as particles having a size between 100 and 500 microns.

5. The topical mixture according to claim 1 wherein the combination of synthetic peptides also includes sh-polypeptide-2 and sh-polypeptide-9 and wherein an amount of sh-polypeptide-71 in the combination of synthetic peptides is lowest and an amount of sh-oligopeptide-1 in the combination of synthetic peptides is greatest.

6. The topical mixture according to claim 1 wherein the combination of synthetic peptides also includes sh-polypeptide-1 and sh-polypeptide-9 and wherein an amount of sh-oligopeptide-1 in the combination of synthetic peptides is lowest and an amount of sh-polypeptide-71 in the combination of synthetic peptides is greatest.

7. The topical mixture according to claim 6 wherein, in the combination of synthetic peptides, sh-polypeptide-7, sh-oligopeptide-4, sh-polypeptide-1, sh-polypeptide-9, and sh-polypeptide-11 are provided in an approximately equal amounts that are between the amount of sh-oligopeptide-1 and the amount sh-polypeptide-71.

8. The topical mixture according to claim 1 wherein the combination of synthetic peptides also includes sh-polypeptide-1.

9. The topical mixture according to claim 8 wherein the inactive components include at least one solvent, a surfactant, an antioxidant, a masking agent, and a smoothing agent.

10. The topical mixture according to claim 9 wherein the solvents are pentylene glycol and water, the surfactant is polysorbate, the antioxidant is ascorbyl glucoside, the chelator is disodium ethylenediaminetetaacetic acid, the smoothing agent is niacinamide.

11. The topical mixture according to claim 8 wherein the inactive components consist essentially of pentylene glycol, water, polysorbate, ascorbyl glucoside, disodium ethylenediaminetetraacetic acid, niancinamide, panethenol, and arginine.

12. A method of preparing the topical mixture of claim 9 comprising:

mixing the inactive components into a solvent to create a solution;

heating the solution to 50° C.; and

allowing the solution to cool to less than 40° C. and then mixing the combination of synthetic peptides into the solution.

13. The method according to claim 10 wherein the combination of synthetic peptides are mixed into the solution when the solution is at approximately 35° C.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2018
From: BARTHOLOMEUSZ, JAMES
To: SKINQRI, LLC
Reel/Frame 047393/0815 →
Continuity (2)
Provisional Application 62581103 · Nov 3, 2017
Related Publication 20190134142A1 · May 9, 2019
Cited By (1)
US 12,303,470